Pediatric ADHD Medication Exposures Reported to US Poison Control Centers
The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Abstract
OBJECTIVES: To describe the characteristics and trends of exposures to attention-deficit/hyperactivity disorder (ADHD) medications among individuals 0 to 19 years old reported to US poison control centers. METHODS: National Poison Data System data from 2000 through 2014 were retrospectively analyzed to examine pediatric ADHD medication exposures. RESULTS: From 2000 through 2014, there were 156 365 exposures reported to US poison control centers related to ADHD medications. The overall rate of reported exposures increased 71.2% from 2000 to 2011, followed by a 6.2% decrease from 2011 to 2014. Three-fourths (76.0%) of exposures involved children ≤12 years old. Methylphenidate and amphetamine medications accounted for 46.2% and 44.5% of exposures, respectively. The most common reason for exposure was therapeutic error (41.6%). Intentional medication exposures (including suspected suicide and medication abuse and/or misuse) were reported most often among adolescents (13–19 years old), accounting for 50.2% of exposures in this age group. Overall, the majority of exposed individuals (60.4%) did not receive health care facility treatment; however, 6.2% were admitted to a hospital for medical treatment, and there were 3 deaths. The increasing number and rate of reported ADHD medication exposures during the study period is consistent with increasing trends in ADHD diagnosis and medication prescribing. Exposures associated with suspected suicide or medication abuse and/or misuse among adolescents are of particular concern. CONCLUSIONS: Unintentional and intentional pediatric exposures to ADHD medications are an increasing problem in the United States, affecting children of all ages.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Large studies of calls to U.S. poison control centers related to ADHD medications find that intentional exposures, including suspected suicide and medication abuse and/or misuse is associated with admission to critical care units and, rarely, death especially when snorted or injected (Faraone et al., 2019a; King et al., 2018).”
From The World Federation of ADHD International Consensus Statement: 208 Evidence-based conclusions about the disorder (2021) · cites this paper as King et al., 2018
In the citing paper
“Moreover, poor responsiveness, pharmacological tolerance, risk of poisoning, high risk of misuse and improper use (e.g. despite contraindications) are common concerns of ADHD medications21–23.”
From Effects of l-theanine–caffeine combination on sustained attention and inhibitory control among children with ADHD: a proof-of-concept neuroimaging RCT (2020) · cites this paper as [21]
Citations
Cites
Subcommittee on Attention-Deficit/Hyperactivity Disorder, S. C. O. Q. I. A. M. (2011) · Pediatrics · doi:10.1542/peds.2011-2654 · Cited by 2,185
Prevalence of attention-deficit/hyperactivity disorder: a systematic review and meta-analysis
Thomas, R., Sanders, S., Doust, J., Beller, E., & Glasziou, P. (2015) · Pediatrics · doi:10.1542/peds.2014-3482 · Cited by 1,976
Visser, S. N., Danielson, M. L., Bitsko, R. H., Holbrook, J. R., Kogan, M. D., Ghandour, R. M., Perou, R., & Blumberg, S. J. (2014) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2013.09.001 · Cited by 1,263
Miech, R. A., Johnston, L. D., O'Malley, P. M., Bachman, J. G., Schulenberg, J. E., & Patrick, M. E. (2018) · doi:10.3998/2027.42/146530 · Cited by 755
(2010) · PsycEXTRA Dataset · doi:10.1037/e664852010-002 · Cited by 456
Approved and Investigational Uses of Modafinil: An Evidence-Based Review
Kumar, R. (2008) · Drugs · doi:10.2165/00003495-200868130-00003 · Cited by 415
Mowry, J. B., Spyker, D. A., Brooks, D. E., Zimmerman, A., & Schauben, J. L. (2016) · Clinical Toxicology · doi:10.1080/15563650.2016.1245421 · Cited by 381
Trends of Outpatient Prescription Drug Utilization in US Children, 2002–2010
Chai, G., Governale, L., McMahon, A. W., Trinidad, J. P., Staffa, J., & Murphy, D. (2012) · Pediatrics · doi:10.1542/peds.2011-2879 · Cited by 370
(2008) · PubMed · Cited by 334
Treatment of Attention-Deficit/Hyperactivity Disorder: Overview of the Evidence
Brown, R. T., Amler, R. W., Freeman, W. S., Perrin, J. M., Stein, M. T., Feldman, H. M., Pierce, K., Wolraich, M. L., & and the Committee on Quality Improvement, S. O. A.-D. D. (2005) · Pediatrics · doi:10.1542/peds.2004-2560 · Cited by 330
Adolescents' Motivations to Abuse Prescription Medications
Boyd, C. J., McCabe, S. E., Cranford, J. A., & Young, A. (2006) · Pediatrics · doi:10.1542/peds.2006-1644 · Cited by 271
The American Association of Poison Control Centers
Mofenson, H. C. (1974) · Clinical Pediatrics · doi:10.1177/000992287401300401 · Cited by 199
Cox, E. R., Motheral, B. R., Henderson, R. R., & Mager, D. (2003) · Pediatrics · doi:10.1542/peds.111.2.237 · Cited by 181
Medical and nonmedical stimulant use among adolescents: from sanctioned to unsanctioned use.
Poulin, C. (2001) · Europe PMC (PubMed Central) · Cited by 178
Spiller, H. A., Hays, H. L., & Aleguas, A. (2013) · CNS Drugs · doi:10.1007/s40263-013-0084-8 · Cited by 156
Self-citationThe Growing Impact of Pediatric Pharmaceutical Poisoning
Bond, G. R., Woodward, R. W., & Ho, M. L. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.07.042 · Cited by 151
Amphetamine Effects in Man: Paradoxical Drowsiness and Lowered Electrical Brain Activity (CNV)
Tecce, J. J., & Cole, J. O. (1974) · Science · doi:10.1126/science.185.4149.451 · Cited by 128
Setlik, J., Bond, G. R., & Ho, M. (2009) · Pediatrics · doi:10.1542/peds.2008-0931 · Cited by 125
Ethnic and Regional Differences in Primary Care Visits for Attention-Deficit Hyperactivity Disorder
STEVENS, J., HARMAN, J. S., & KELLEHER, K. J. (2004) · Journal of Developmental & Behavioral Pediatrics · doi:10.1097/00004703-200410000-00003 · Cited by 102
Unit-Dose Packaging of Iron Supplements and Reduction of Iron Poisoning in Young Children
Tenenbein, M. (2005) · Archives of Pediatrics & Adolescent Medicine · doi:10.1001/archpedi.159.6.557 · Cited by 80
Preventing Medication Overdoses in Young Children: An Opportunity for Harm Elimination
Budnitz, D. S., & Salis, S. (2011) · Pediatrics · doi:10.1542/peds.2011-0926 · Cited by 58
Characterization of Methylphenidate Exposures Reported to a Regional Poison Control Center
White, S. R., & Yadao, C. M. (2000) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.154.12.1199 · Cited by 47
A Profile of Methylphenidate Exposures
Foley, R., Mrvos, R., Krenzelok, E. P., & Krenzelok, E. (2000) · Journal of Toxicology: Clinical Toxicology · doi:10.1081/clt-100102011 · Cited by 43
Primary Pediatric Care Psychopharmacology: Focus on Medications for ADHD, Depression, and Anxiety
Strawn, J. R., Dobson, E. T., & Giles, L. L. (2016) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2016.11.008 · Cited by 43
Trends in child and teen nonprescription drug abuse reported to a regional poison control center
Crouch, B. I., Caravati, E. M., & Booth, J. (2004) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/61.12.1252 · Cited by 42
Determinants of U.S. poison center utilization
Litovitz, T. L., Benson, B. E., Youniss, J., et al. (2010) · Clinical Toxicology · doi:10.3109/15563651003757947 · Cited by 41
Effects of FDA Advisories on the Pharmacologic Treatment of ADHD, 2004–2008
Kornfield, R., Watson, S., Higashi, A. S., Conti, R. M., Dusetzina, S. B., Garfield, C. F., Dorsey, E. R., Huskamp, H. A., & Alexander, G. C. (2013) · Psychiatric Services · doi:10.1176/appi.ps.201200147 · Cited by 40
Comparison of lisdexamfetamine and dextroamphetamine exposures reported to U.S. poison centers
Kaland, M. E., & Klein-Schwartz, W. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1027903 · Cited by 39
Pediatric Methylphenidate Exposures: 7-Year Experience of Poison Centers in the United States
Klein-Schwartz, W. (2003) · Clinical Pediatrics · doi:10.1177/000992280304200210 · Cited by 39
Wang, G. S., Lait, M. L., & Heard, K. J. (2013) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2013.08.038 · Cited by 36
ADHD in children and adolescents.
Keen, D. V., & Hadijikoumi, I. (2008) · Europe PMC (PubMed Central) · Cited by 33
Dawes, D., & Kilmer, G. (2012) · Cited by 27
Levine, M., Froberg, B. A., Ruha, A., Ewald, M. B., Yen, M., Claudius, I. A., Arthur, A. O., Tormoehlen, L. M., & Thomas, S. H. (2013) · Clinical Toxicology · doi:10.3109/15563650.2013.772623 · Cited by 16
Hondebrink, L., Rietjens, S. J., Hunault, C. C., Pereira, R. R., Kelleci, N., Yasar, G., Ghebreslasie, A., Lo-A-Foe, C., de Vries, I., & Meulenbelt, J. (2015) · Clinical Toxicology · doi:10.3109/15563650.2015.1004579 · Cited by 11
A clinican's guide to adult attention-deficit hyperactivity disorder.
Modesto‐Lowe, V., Meyer, A. H., & Soovajian, V. (2012) · PubMed · Cited by 9
Cited by
Faraone, S. V., Banaschewski, T., Coghill, D., Zheng, Y., Biederman, J., Bellgrove, M. A., Newcorn, J. H., Gignac, M., Al Saud, N. M., Manor, I., et al. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.022 · Cited by 1,545
“especially when snorted or injected (Faraone et al., 2019a; King et al., 2018).”
Faraone, S. V., Rostain, A. L., Montano, C. B., Mason, O., Antshel, K. M., & Newcorn, J. H. (2020) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2019.06.012 · Cited by 225
Kahathuduwa, C. N., Wakefield, S., West, B. D., Blume, J., Dassanayake, T. L., Weerasinghe, V. S., & Mastergeorge, A. (2020) · Scientific Reports · doi:10.1038/s41598-020-70037-7 · Cited by 45
King, N., Floren, S., Kharas, N., Thomas, M., & Dafny, N. (2019) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2019.172737 · Cited by 13
Metadata
- Authors
- King, S. A., Casavant, M. J., Spiller, H. A., Hodges, N. L., Chounthirath, T., & Smith, G. A.
- Affiliations
- Nationwide Children's Hospital (US)
- The Ohio State University (US)
- Center for Injury Research and Policy, The Research Institute at Nationwide Children’s Hospital, Columbus, Ohio;
- Venue
- Pediatrics
- Publisher
- American Academy of Pediatrics (AAP)
- Published
- 2018-06-01
- Volume
- 141
- Issue
- 6
- ISSN
- 0031-4005 (ISSN-L)
- 1098-4275
- OpenAlex
- W2807613355
- Semantic Scholar
- 63ebcdd21eda8f4a3fa0c37130ff81316f9aaabc
- Cited by
- 30
- References
- 35
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 6 · 2020: 4 · 2019: 6
- FWCI
- 4.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- PEDIATRICS (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
- Keywords
- ADHD medication, poison control centers, methylphenidate, amphetamine, treatment errors, adolescent suicide, medication misuse, exposure trends, National Poison Data System
- MeSH terms
- Atomoxetine Hydrochloride, Drug Misuse, Modafinil, Adolescent, Amphetamine, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Child, Preschool, Humans, Infant, Infant, Newborn, Medication Errors, Methylphenidate, Patient Admission, Poison Control Centers, Retrospective Studies, Suicide, Attempted, United States, Age Distribution, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.